Hyun Duk Jang

Title: Hyun Duk Jang: Innovator in Pharmaceutical Composition

Introduction

Hyun Duk Jang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on polypeptides derived from CAP1. With a total of two patents to his name, Jang's research focuses on developing effective treatments for various inflammatory diseases and conditions.

Latest Patents

Jang's latest patents include a polypeptide derived from CAP1 and a pharmaceutical composition comprising the same as an effective ingredient. This invention relates to a peptide that includes a specific amino acid sequence and additional amino acid residues. The pharmaceutical composition is designed for the prevention and alleviation of inflammatory diseases, cancer, diabetes, fatty hepatitis, arteriosclerosis, cardiovascular diseases, and heart failure. The method exhibits the ability to suppress the binding of resistin to CAP1 and inhibit NF-kB activity, making it a promising approach for treating conditions caused by the activation of these factors.

Career Highlights

Hyun Duk Jang is affiliated with Seoul National University, where he conducts his research and development work. His academic background and ongoing research contribute to advancements in the pharmaceutical industry, particularly in the area of disease prevention and treatment.

Collaborations

Jang collaborates with notable colleagues, including Hyo Soo Kim and Sang Eun Lee. Their combined expertise enhances the research efforts and innovation in the field of pharmaceuticals.

Conclusion

Hyun Duk Jang is a key figure in the development of innovative pharmaceutical compositions aimed at addressing critical health issues. His work continues to pave the way for advancements in medical treatments and therapies.